ICBR acquires Illumina NextSeq 500, MiSeq, and Life Technologies Ion Proton™ sequencers

Published: May 2nd, 2014

Category: All News, Announcements, Featured News, NextGen DNA Sequencing

The ICBR NextGen DNA Sequencing core has committed to increasing sequencing capabilities with the acquisition of three new instruments, available summer 2014. Customers will benefit from the full-service offerings, allowing faster project initiation and data delivery at lower costs.

The Illumina NextSeq 500 packs powerful and efficient high-throughput sequencing into an affordable desktop form. With increased capacity and rapid turnaround times, researchers can perform the most popular sequencing applications in one to three days. The first high-throughput desktop sequencer to offer Exome, Transcriptome and Whole-genome sequencing on demand, the NextSeq 500 offers customers local sequencing and high-quality data from Illumina.

  • Up to 800 million paired-end reads in high-throughput mode
  • Up to 260 million paired-end reads in mid-throughput mode
  • Up to 150 bp read lengths

The Illumina MiSeq is the first personal sequencer with access to applications such as targeted gene sequencing, metagenomics, small genome sequencing, targeted gene expression, amplicon sequencing, and HLA typing. The lower-throughput MiSeq provides the fastest turnaround time of any next-generation desktop sequencing system. The touchscreen interface matched with a smaller platform simplifies the sequencing process and broadens its availability.

  • Up to 50 million paired-end reads
  • Up to 300 bp read lengths

ICBR strives to provide technological options for customers. Through semiconductor sequencing technology, the Life Technologies Ion Proton™ System provides simple, fast and cost-effective sequencing. Each system utilizes powerful semiconductor chips with varying configurations and output to accommodate even the most data-demanding applications.

Contact the NextGen DNA Sequencing core at ICBR-NextGenSeq@ad.ufl.edu for more on the availability of its new sequencing instruments and available services. For assistance in interpretation of data, contact the ICBR Bioinformatics core at ICBR-Bioinformatics@ad.ufl.edu.

 

 

 

 

 

 

 

Comments are currently closed.